MedAdvisor Limited announced the appointment of Kate Hill and Brett Magun as non-executive directors, effective 24 May 2023. Ms Hill is an experienced non-executive director and previously spent over 20 years as an audit partner at Deloitte, serving both ASX listed and privately owned clients. Kate has particular expertise at board level in both technology companies and also the biotech and medical devices sectors.

Mr. Magun is the nominated board member of Cotiviti Inc. (Cotiviti), replacing RaeAnn Grossman who resigned on 21 April 2023. Cotiviti is a leading healthcare technology business in the United States. Brett will add valuable guidance for the continued expansion of MedAdvisor's business in the United States.

Ms Sandra Hook has been appointed as Chair of the People, Remuneration and Nominations Committee. Current Chair of the People, Remuneration and Nominations Committee, Jim Xenos will step down as Chair and continue to support the business with a focus on the expansion of the capability in the Australian market. Kate Hill will become Chair of the Audit and Risk Committee, previously held by Sandra Hook.

These committee changes take effect 1 July 2023. Kate is an experienced non-executive director of ASX-listed companies and brings expertise at board level in leading change involving new business models, markets and technologies in the biotech and medical device sectors. In addition, she has experience on other listing exchanges including Nasdaq (US) and AIM (UK).

Kate spent more than 20 years as an audit partner at Deloitte, serving both ASX-listed and private clients. She has deep experience helping companies navigate evolving operating environments - with a focus on sustainable growth leading to profitability along with extensive M&A and capital raising experience; and stakeholder engagement including investor relations, proxy solicitation and media management. Kate has strong governance skills with deep expertise in all aspects of compliance in regulated markets and Audit and Risk Committee leadership.

She has a Bachelor of Science (Honours) in Mathematics and Statistics from Bristol University. Brett Magun is the Senior Vice President, General Counsel and Corporate Secretary of Cotiviti Inc. where he oversees the company's legal and compliance functions globally. This includesadvising the Company and its Board on employment, corporate, contractual, and complex corporate transaction-related risks and solutions.

Brett has spent more than 25 years as an in-house corporate attorney providing counsel forlarge corporations and start-ups, both domestically and abroad. These include General Counsel to Richard Branson's Virgin Money US entity, and various legal roles for KPMG in the Netherlands and Bear Stearns in New York City. Brett has a Juris Doctorate from Brooklyn Law School where he was a Richardson Scholar and a Bachelor of Science in Business Administration from Boston University.